Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Subcutaneous Insulin Lispro Safe and Effective for Diabetic Ketoacidosis

Posted: Wednesday, September 29, 2004

 
Unlike regular insulin, which is continuously pumped into the veins when treating DKA, lispro is given intermittently with shots. As a result, regular insulin therapy usually requires treatment in the intensive care unit, whereas lispro does not. For this reason, .

Dr. Guillermo E. Umpierrez, from Emory University in Atlanta, assessed the outcomes of 40 diabetic ketoacidosis patients who were randomized to receive subcutaneous insulin lispro or intravenous regular insulin.

All of the subjects in the regular insulin group were treated in the ICU, whereas half the insulin lispro subjects were treated on a medicine ward and half were treated in a step-down unit.

The patients' biochemical parameters on admission were similar in each group, the researchers point out. Moreover, the time needed to correct the biochemical abnormalities was comparable in each group--about 7 hours were required to correct the hyperglycemia and around 10.5 hours were needed to resolve the ketoacidosis.

The groups were also similar in terms of length of hospital stay, hypoglycemia rate, and the amount of insulin used before ketoacidosis resolution. No deaths occurred in either group.
The average hospitalization charge for diabetic ketoacidosis treated in the ICU setting was $14,429, almost 40% higher than the charge for treatment with lispro in non-ICU settings, at $8801 (p < 0.01).

The findings "raise interesting questions regarding the most cost-effective and labor-saving methods for treating a common disease in the hospital setting," Dr. Romana M. Haas and Dr. Andrew R. Hoffman, from Stanford University in California, note in a related editorial.

"Since many cases of uncomplicated DKA are now being treated in emergency departments or overnight treatment units, it will be important to perform similar analyses in these settings.

Source: Diabetes In Control.com:

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement